These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11491461)

  • 41. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors.
    Arien-Zakay H; Lecht S; Bercu MM; Tabakman R; Kohen R; Galski H; Nagler A; Lazarovici P
    Exp Neurol; 2009 Mar; 216(1):83-94. PubMed ID: 19070617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium.
    Toriniwa H; Komiya T
    Vaccine; 2008 Jul; 26(29-30):3680-9. PubMed ID: 18534722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Schwann cell secreted factors on PC12 cell neuritogenesis and survival.
    Bampton ET; Taylor JS
    J Neurobiol; 2005 Apr; 63(1):29-48. PubMed ID: 15702477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assay of specific antibodies produced in organs of mice immunized with nerve growth factor.
    Lipps BV
    J Nat Toxins; 2002 Aug; 11(3):149-53. PubMed ID: 12182534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms involved in suppression of NGF-induced neuronal differentiation of PC12 cells by hyaluronic acid.
    Washio A; Kitamura C; Jimi E; Terashita M; Nishihara T
    Exp Cell Res; 2009 Oct; 315(17):3036-43. PubMed ID: 19615362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extremely low nerve growth facior (NGF) activity of sea snake (Hydrophiidae) venoms.
    Mariam K; Tu AT
    J Nat Toxins; 2002 Dec; 11(4):393-8. PubMed ID: 12503884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biologically active anti-nerve growth factor antibodies in commercial intravenous gammaglobulin.
    Warrington RJ; Lewis KE
    J Autoimmun; 2007 Feb; 28(1):24-9. PubMed ID: 17218083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on the isolation, structure identification and biological function of two tumor cell suppressors of human fetal liver origin].
    Zhang QL; Wu ZZ; Cao JR; Xue HH; Pei XT; Wang LS; Xu L; Du ZH; Feng R
    Sheng Li Xue Bao; 1997 Jun; 49(3):327-32. PubMed ID: 9812819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of NGF on acetylcholine, acetyl-CoA metabolism, and viability of differentiated and non-differentiated cholinergic neuroblastoma cells.
    Szutowicz A; Madziar B; Pawełczyk T; Tomaszewicz M; Bielarczyk H
    J Neurochem; 2004 Aug; 90(4):952-61. PubMed ID: 15287901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of new anti-neutral glycosphingolipids antibodies and their effects on Trk neurotrophin receptors.
    Mihara T; Ueda A; Hirayama M; Takeuchi T; Yoshida S; Naito K; Yamamoto H; Mutoh T
    FEBS Lett; 2006 Sep; 580(21):4991-5. PubMed ID: 16935282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation.
    Bergonzini V; Delbue S; Wang JY; Reiss K; Prisco M; Amini S; Khalili K; Peruzzi F
    Oncogene; 2004 Oct; 23(46):7701-11. PubMed ID: 15361847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
    Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
    BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nerve growth factor-induced migration of endothelial cells.
    Dollé JP; Rezvan A; Allen FD; Lazarovici P; Lelkes PI
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1220-7. PubMed ID: 16123305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nerve growth factors from snake venoms: chemical properties, mode of action and biological significance.
    Kostiza T; Meier J
    Toxicon; 1996 Jul; 34(7):787-806. PubMed ID: 8843580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells.
    Su F; Kozak KR; Herschman H; Reddy ST; Farias-Eisner R
    J Neurosci Res; 2007 Jul; 85(9):1952-8. PubMed ID: 17455298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of low-affinity p75 receptor in nerve growth factor-inducible growth arrest of PC12 cells.
    Ito H; Nomoto H; Furukawa S
    J Neurosci Res; 2002 Sep; 69(5):653-61. PubMed ID: 12210831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nerve growth factor from the venom of the Chinese cobra Naja naja atra: purification and description of non-neuronal activities.
    Kostiza T; Dahinden CA; Rihs S; Otten U; Meier J
    Toxicon; 1995 Oct; 33(10):1249-61. PubMed ID: 8599177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.